CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common stock	Additional paid-in capital	Additional paid-in capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive loss	Accumulated deficit	Accumulated deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jun. 30, 2021			94,504
Beginning balance at Jun. 30, 2021	$ 2,529,590	$ (216,066)	$ 2	$ 2,777,155	$ (245,066)	$ (100)	$ (247,467)	$ 29,000
Issuance of common stock upon public offering, net of underwriting discounts and other offering costs (in shares)			5,074
Issuance of common stock upon public offering, net of underwriting discounts and other offering costs	1,341,122			1,341,122
Issuance of common stock as consideration for an acquisition, net of issuance costs (in shares)			1,788
Issuance of common stock as consideration for an acquisition, net of issuance costs	488,263			488,263
Fair value of replacement awards	26,710			26,710
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)			1,033
Issuance of common stock upon exercise of stock options and release of restricted stock units	8,644			8,644
Issuance of common stock under the employee stock purchase plan (in shares)			40
Issuance of common stock under the employee stock purchase plan	5,726			5,726
Purchase of capped calls	(37,893)			(37,893)
Stock-based compensation	38,839			38,839
Other comprehensive loss	(39)					(39)
Net loss	(74,259)						(74,259)
Ending balance (in shares) at Sep. 30, 2021			102,439
Ending balance at Sep. 30, 2021	4,110,637		$ 2	4,403,500		(139)	(292,726)
Beginning balance (in shares) at Jun. 30, 2022			104,731
Beginning balance at Jun. 30, 2022	4,043,694		$ 2	4,598,737		(10,217)	(544,828)
Issuance of common stock upon exercise of stock options and release of restricted stock units (in shares)			835
Issuance of common stock upon exercise of stock options and release of restricted stock units	8,494			8,494
Issuance of common stock under the employee stock purchase plan (in shares)			67
Issuance of common stock under the employee stock purchase plan	3,901			3,901
Stock-based compensation	73,352			73,352
Other comprehensive loss	(270)					(270)
Net loss	(81,640)						(81,640)
Ending balance (in shares) at Sep. 30, 2022			105,633
Ending balance at Sep. 30, 2022	$ 4,047,531		$ 2	$ 4,684,484		$ (10,487)	$ (626,468)